ORAGENICS, INC. Preferred Stock, Value, Issued
ORAGENICS, INC. (OGEN) had Preferred Stock, Value, Issued of $1.59 million as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:PreferredStockValue · last filed 2025-03-14
- 2024-09-30: Preferred Stock, Value, Issued $1.59M.
- 2024-06-30: Preferred Stock, Value, Issued $1.59M.
- 2024-03-31: Preferred Stock, Value, Issued $1.59M.
- 2023-12-31: Preferred Stock, Value, Issued $1.59M.
| Period end | Preferred Stock, Value, Issued |
|---|---|
| 2024-09-30 | $1.59M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.59M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.59M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.59M 10-K · filed 2025-03-14 |
| 2023-09-30 | $1.59M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.59M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.59M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $1.59M 10-K · filed 2024-03-29 |
| 2022-09-30 | $1.59M 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $2.66M 10-Q/A · filed 2023-04-14 |
| 2022-03-31 | $2.66M 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $2.66M 10-K · filed 2023-04-17 |
| 2021-09-30 | $2.66M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.66M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $2.66M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $7.17M 10-K/A · filed 2022-07-29 |
| 2020-09-30 | $7.17M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $7.17M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $7.17M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $6.51M 10-K · filed 2021-03-01 |
| 2019-09-30 | $6.51M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $6.51M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $6.51M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $6.10M 10-K · filed 2020-03-04 |
| 2018-09-30 | $6.81M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $6.10M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $6.10M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $6.31M 10-K · filed 2019-03-29 |
| 2017-09-30 | $1.25M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $482.21K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-15 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-03 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-05 |
| 2010-12-31 | $0.00 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |